PRA Health Sciences Expands its Response to COVID-19 with Pharmacovigilance Solutions for Authorized Vaccines and Therapeutics

RALEIGH, N.C., April 21 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including post-authorization safety studies (PASS) delivered by Real World Solutions. With more than 25 years of experience executing comprehensive pharmacovigilance and patient safety services [...]